WO2007096733A3 - Desloratadine-containing formulation stabilized with cyclodextrin - Google Patents

Desloratadine-containing formulation stabilized with cyclodextrin Download PDF

Info

Publication number
WO2007096733A3
WO2007096733A3 PCT/IB2007/000385 IB2007000385W WO2007096733A3 WO 2007096733 A3 WO2007096733 A3 WO 2007096733A3 IB 2007000385 W IB2007000385 W IB 2007000385W WO 2007096733 A3 WO2007096733 A3 WO 2007096733A3
Authority
WO
WIPO (PCT)
Prior art keywords
desloratadine
cyclodextrin
containing formulation
formulation stabilized
pharmaceutical composition
Prior art date
Application number
PCT/IB2007/000385
Other languages
French (fr)
Other versions
WO2007096733A2 (en
Inventor
Mathivanan Natarajan
Sreekanth Joginapalli
Praveen Reddy Billa
Original Assignee
Orchid Chemicals & Pharm Ltd
Mathivanan Natarajan
Sreekanth Joginapalli
Praveen Reddy Billa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orchid Chemicals & Pharm Ltd, Mathivanan Natarajan, Sreekanth Joginapalli, Praveen Reddy Billa filed Critical Orchid Chemicals & Pharm Ltd
Priority to EP07733895A priority Critical patent/EP1988893A4/en
Publication of WO2007096733A2 publication Critical patent/WO2007096733A2/en
Publication of WO2007096733A3 publication Critical patent/WO2007096733A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins

Abstract

The present invention relates to a stable oral pharmaceutical composition. More particularly the invention relates to a stable oral pharmaceutical composition containing desloratadine and a process for preparing the stable oral pharmaceutical composition.
PCT/IB2007/000385 2006-02-22 2007-02-19 Desloratadine-containing formulation stabilized with cyclodextrin WO2007096733A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP07733895A EP1988893A4 (en) 2006-02-22 2007-02-19 Desloratadine-containing formulation stabilized with cyclodextrin

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN289/CHE/2006 2006-02-22
IN289CH2006 2006-02-22

Publications (2)

Publication Number Publication Date
WO2007096733A2 WO2007096733A2 (en) 2007-08-30
WO2007096733A3 true WO2007096733A3 (en) 2007-11-08

Family

ID=38437741

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2007/000385 WO2007096733A2 (en) 2006-02-22 2007-02-19 Desloratadine-containing formulation stabilized with cyclodextrin

Country Status (2)

Country Link
EP (1) EP1988893A4 (en)
WO (1) WO2007096733A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE525064T1 (en) 2009-07-01 2011-10-15 Tiefenbacher Alfred E Gmbh & Co Kg PHARMACEUTICAL COMPOSITION CONTAINING DESLORATADINE
CN102697711B (en) * 2012-05-24 2013-10-30 广州新济药业科技有限公司 Desloratadine oral liquid preparation and preparation method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003101434A2 (en) * 2001-12-21 2003-12-11 Sampad Bhattacharya Intranasal pharmaceutical compositions comprising an antihistamine and a leukotriene inhibitor
WO2005008674A2 (en) * 2003-07-16 2005-01-27 Infineon Technologies Ag Semiconductor memory having a short effective word-line cycle time and data readout method for said semi-conductor memory
JP2005053825A (en) * 2003-08-04 2005-03-03 Nidek Co Ltd Composition for instillation or rhinenchysis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2276801A (en) * 1999-12-20 2001-07-03 Schering Corporation Extended release oral dosage composition
US7955620B2 (en) * 2003-12-23 2011-06-07 Sun Pharmaceutical Industries Limited Stable oral composition

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003101434A2 (en) * 2001-12-21 2003-12-11 Sampad Bhattacharya Intranasal pharmaceutical compositions comprising an antihistamine and a leukotriene inhibitor
WO2005008674A2 (en) * 2003-07-16 2005-01-27 Infineon Technologies Ag Semiconductor memory having a short effective word-line cycle time and data readout method for said semi-conductor memory
JP2005053825A (en) * 2003-08-04 2005-03-03 Nidek Co Ltd Composition for instillation or rhinenchysis

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1988893A4 *

Also Published As

Publication number Publication date
EP1988893A2 (en) 2008-11-12
EP1988893A4 (en) 2010-05-26
WO2007096733A2 (en) 2007-08-30

Similar Documents

Publication Publication Date Title
WO2007121318A3 (en) Formulations for delivering insulin
AU2013257508A1 (en) Pharmaceutical compositions
IL193772A0 (en) 4-oxoquinoline derivatives,methods for the preparation thereof and pharmaceutical compositions containing the same
AP2416A (en) Stabilized pharmaceutical compositions comprising fesoterodine.
IL178544A (en) Δ-crystalline form of ivabradine hydrochlorioe, a process for its preparation and pharmaceutical compositions containing it
EP2057987A4 (en) Pharmaceutical composition containing statin-encapsulated nanoparticle
AP2384A (en) 1,2,4,5-tetrahydro-3H-benzazepine compounds, a process for their preparation and pharmaceutical compositions containing them.
WO2007124855A3 (en) Antiseptic-containing silicone elastomers
WO2008113901A3 (en) Composition with controlled release of levetiracetam and method for preparing same
EP1941896A4 (en) Dipeptide-containing composition for oral administration
IL193774A0 (en) Pharmaceutical compositions containing a 3,5-seco-4-norcholestane derivative
SI2231598T1 (en) Novel diazeniumdiolate derivatives, method for the preparation thereof and pharmaceutical compositions containing the same
IL186862A0 (en) Novel phenyl-pyridinyl-piperazine derivatives, a method for the production thereof and pharmaceutical compositions containing said derivatives
ZA200902414B (en) Indole derivatives, process for the preparation thereof and pharmaceutical compositions containing them
HK1126190A1 (en) Novel pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamines, process for the preparation thereof and pharmaceutical compositions containing them
WO2007124869A3 (en) Liquid pharmaceutical formulation
WO2008060546A3 (en) Oral formulations
WO2007096733A3 (en) Desloratadine-containing formulation stabilized with cyclodextrin
IL192963A0 (en) Rimonabant monohydrate, process for the preparation thereof and pharmaceutical compositions containing same
IL206936A0 (en) 2-amino-2-phenylalkanol derivatives, preparation thereof and pharmaceutical compositions containing same
ZA200902413B (en) Novel indole derivatives, process for the preparation thereof and pharmaceutical compositions containing them
WO2009010298A8 (en) Paullone derivatives and its use
IL189177A0 (en) Process for producing carcosporamide and pharmaceutical compositions containing cercosporamide
ZA200805656B (en) Prodrug ER²-selective substances, methods for the production thereof and pharmaceutical compositions containing said compounds
AU2006907173A0 (en) Pharmaceutical Composition

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2007733895

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE